Alleviation of constant-light-induced photoreceptor degeneration by adaptation of adult albino rat to bright cyclic light
Alleviation of constant-light-induced photoreceptor degeneration by adaptation of adult albino rat to bright cyclic light
复制标题
DOI:
10.1167/iovs.03-0140
复制
发表时间:
2003-11-01
影响因子:
4.4
通讯作者:
Anderson, RE
中科院分区:
文献类型:
--
作者:
Li, F;Cao, W;Anderson, RE
PURPOSE. To further test the hypothesis that fight-adaptation-mediated photoreceptor protection works through inhibition of apoptosis by activation and/or upregulation of neuroprotective molecules.METHODS. Albino rats were born and raised in 5-lux cyclic fight (12 hours OFF and ON). At 8 weeks of age, animals were adapted to 400-lux cyclic fight for different periods. Light damage was induced by exposure to constant fight for I day at an illumination of 1700 lux. Animals were killed, and their eyes were removed for morphometric and biochemical analysis. TUNEL assay was used to evaluate photoreceptor cell apoptosis and Western blot analyses were used to determine the levels of basic fibroblast growth factor (bFGF), neuronal nitric oxide synthase (nNOS), and caspase-3.RESULTS. Exposure of dim-reared rats to constant fight for 1 day dramatically increased TUNEL-positive cells in the outer nuclear layer. Adaptation to 400-lux bright cyclic fight for 4 days significantly reduced TUNEL-positive cells induced by exposure to constant light, which correlated with a significant increase in bFGF expression. Compared with control retinas, caspase-3 levels were not changed by exposure to constant light or after adaptation to 400 lux. There was a significant increase in nNOS level in the constant-light- exposed group, but not in the group adapted to 400-lux bright light before exposure to constant light.CONCLUSIONS. The retina of the adult rat can rapidly upregulate neuroprotective mechanisms when switched from dim to bright cyclic fight. Identification of the molecules involved in this process may allow rational development of therapeutic approaches to treat retinal degenerative diseases.